Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis: A Clinical Trial

NCT05660694 is registered in ClinicalTrials.gov with Altamash Institute of Dental Medicine as lead sponsor.

NCT NCT05660694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05660694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis: A Clinical Trial
Lead sponsor
Altamash Institute of Dental Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2020
Completion date
September 30, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral submucosa fibrosis, pentoxifylline, triamcinolone, tumor, vitamin e